Is Denali Therapeutics Inc. (DNLI) a Buy, Sell, or Hold?
Denali Therapeutics Inc.
NASDAQ:DNLI
$23.02 USD
$0.37 (1.63%)
- Volume
- 1.89M
- Average Volume
- 1.83M
- Market Capitalization
- $3.65B
- P/E Ratio
- -7.99
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $27.30
- Year Low
- $12.58
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.28
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-34.2% DOWNSIDE
$35.00 Price Target
UPSIDE/DOWNSIDE HIGH
-43.9% DOWNSIDE
$41.00 Price Target High
UPSIDE/DOWNSIDE LOW
-11.5% DOWNSIDE
$26.00 Price Target Low
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Wedbush | Laura Chico | $26 | $25.3337 | 2026-07-13 08:04 AM | 2.6% |
| Stifel Nicolaus | Paul Mattels | $41 | $23.7624 | 2026-06-22 09:26 AM | 72.5% |
| Wedbush | Laura Chico | $23 | $20.11 | 2026-05-08 09:35 AM | 14.4% |
| Jefferies | Andrew Tsai | $40 | $21 | 2026-03-02 05:08 PM | 90.5% |
| Morgan Stanley | Sean Laaman | $40 | $16.95 | 2026-01-08 07:43 AM | 136.0% |
| UBS | Michael Yee | $25 | $17.21 | 2026-01-07 12:41 AM | 45.3% |
| Wedbush | Laura Chico | $30 | $17.61 | 2025-12-11 08:30 AM | 70.4% |